Vaccines for Enteric Diseases

16-18 October 2019, CHUV, University of Lausanne, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size


Join the conversation on Twitter – #VED2019

Vaccines For Enteric Diseases (VED 2019), will address the diverse aspects of vaccines to counter human enteric diseases. With regard to global public health issues, enteric diseases probably represent the first cause of infectious morbidity and second cause of infectious mortality worldwide. The added complications surrounding the increasing resistance to bacterial enteric pathogens to antibiotics are creating a worldwide trend that will require enhanced enteric vaccine strategies. Taking into consideration the major difficulties faced in drastically improving the sanitary conditions in large areas of the developing world which accounts for more than 95% of enteric infections, enteric vaccine strategies may become the prime preventative approach. Enteric infections also present problems in the industrialized world where the food chain continues to be compromised by enteric pathogens.

Scientific Advisory Panel

Duncan Steele (Bill & Melinda Gates Foundation, USA)
Timo Vesikari (University of Tampere, Finland)
Carol O. Tacket (University of Maryland, USA)
Myron M. Levine (University of Maryland, USA)
John D. Clemens (ICDDR, Dhaka, Bangladesh)
Kevin Killeen (Matrivax Corporation, Boston, USA)
Ann-Mari Svennerholm (Göteborg University, Sweden)
Harry B. Greenberg (Stanford University, USA)
Umesh Parashar (CDC, Atlanta, USA)
David Sack (Johns Hopkins University, Baltimore, Maryland, USA)
Armelle Phalipon (Pasteur Institute, Paris, France)
Robert Hall (NIAID/NIH, Bethesda, Maryland, USA)
Ladaporn Bodhidatta (AFRIMS, Bangkok, Thailand)
Bernd Benninghoff (GSK Biologicals, Wavre, Belgium)
Daniel Cohen (Tel Aviv University, Tel Aviv, Israel)
Martin Mengel (Global Health Consulting, Spain)
Jan Holmgren (Goteborg University, Goteborg, Sweden)
Fred Cassels (PATH, Washington DC, USA)
Shahida Baqar (NIAID/NIH, Bethesda, Maryland, USA)
Milton Maciel Jr (Henry M. Jackson Found./Naval Medical Research Center, Silver Spring, Maryland, USA)
Davinder Gill (Hilleman Laboratories, New Delhi, India)
K. Zaman (icddrb, Dhaka, Bangladesh)
Elizabeth Norton (Tulane University, New Orleans, Louisiana, USA)

VED 2019 will be a major opportunity to:

  • Re-evaluate the diarrheal disease burden both in the industrialized and developing worlds
  • Discuss which diseases, depending on the area, would require an immunization strategy and if eradication or control of the selected disease is achievable by a vaccine
  • Discuss the state-of-the-art vaccine candidates currently available
  • Discuss obstacles to obtaining institutional and industrial support for these vaccines · Review of studies in developing countries
  • Air views on the lack of facilities for enteric vaccine trials
  • Discuss the distribution of vaccines and implementation policy in the developing world

VED 2019 Delegates

Login details will be supplied after you have registered for the event.

VED 2019 Sponsors

  • Eveliqure
  • BioVAXX
  • Takeda
  • LimmaTech Biologics
  • Vaccine Research Center
  • Vismederi
  • Sanofi Pasteur
  • Matrivax
  • hVIVO
  • Vaxart
  • Aldevron
  • PATH
  • Scandinavian Biopharma

VED 2019 Downloads

VED 2019 Leaflet

VED 2019 Mailing List

E-mail Address
What is 3+2-1?